Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Geography in multiple sclerosis.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Some recent advances in multiple sclerosis.
Neurological involvement in Primary Sjögren Syndrome.
American Neurological Association Annual 2012 Annual Meeting
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
The 10th European Congress of Neuropathology
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Flupirtine in pain management: pharmacological properties and clinical use.
Use of rituximab in multiple sclerosis: current progress and future perspectives.

Pages